| Jonathan Cardeen Lowry, MD | |
|
335 E Parker Rd, Morganton, NC 28655-5112 | |
| (828) 433-1000 | |
| (828) 433-6274 |
| Full Name | Jonathan Cardeen Lowry |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 335 E Parker Rd, Morganton, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780698274 | NPI | - | NPPES |
| 53145 | Other | NC | BLUE CROSS BLUE SHIELD NC |
| 8916651 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 9500648 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rutherford Regional Medical Center | Rutherfordton, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Morganton Eye Physicians Pa | 7810882818 | 23 |
News Archive
The Procter & Gamble Company reported first quarter diluted net earnings per share from continuing operations of $1.02 per share, an increase of five percent and above the Company's guidance range of $0.97 to $1.01.
Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking "new" ears to thousands of children born with a congenital ear deformity.
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
People who suffer one or more forms of maltreatment in childhood have a higher chance of multimorbidity in later life.
› Verified 9 days ago
| Entity Name | Morganton Eye Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588678817 PECOS PAC ID: 7810882818 Enrollment ID: O20040301000467 |
News Archive
The Procter & Gamble Company reported first quarter diluted net earnings per share from continuing operations of $1.02 per share, an increase of five percent and above the Company's guidance range of $0.97 to $1.01.
Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking "new" ears to thousands of children born with a congenital ear deformity.
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
People who suffer one or more forms of maltreatment in childhood have a higher chance of multimorbidity in later life.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Cardeen Lowry, MD 335 E Parker Rd, Morganton, NC 28655-5112 Ph: (828) 433-1000 | Jonathan Cardeen Lowry, MD 335 E Parker Rd, Morganton, NC 28655-5112 Ph: (828) 433-1000 |
News Archive
The Procter & Gamble Company reported first quarter diluted net earnings per share from continuing operations of $1.02 per share, an increase of five percent and above the Company's guidance range of $0.97 to $1.01.
Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking "new" ears to thousands of children born with a congenital ear deformity.
Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.
People who suffer one or more forms of maltreatment in childhood have a higher chance of multimorbidity in later life.
› Verified 9 days ago
Leighton Alvin Raynor, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 335 E Parker Rd, Morganton, NC 28655 Phone: 828-433-1000 Fax: 828-433-6274 | |
Philip Douglas Kath, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 335 E Parker Rd, Morganton, NC 28655 Phone: 828-433-1000 Fax: 828-433-6274 | |
Dr. Jordan Ambrose Margo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 335 E Parker Rd, Morganton, NC 28655 Phone: 828-433-1000 Fax: 828-430-3465 | |
Dr. Sarah M Escott, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 335 E Parker Rd, Morganton, NC 28655 Phone: 828-433-1000 | |
Dr. Michael Glen Taggart, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 335 E Parker Rd, Morganton, NC 28655 Phone: 828-433-1000 Fax: 828-433-6274 | |
James Arthur Salisbury, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 335 E Parker Rd, Morganton, NC 28655 Phone: 828-433-1000 Fax: 828-433-6274 | |
William Harold Walton Ii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 335 E Parker Rd, Morganton, NC 28655 Phone: 828-433-1000 Fax: 828-433-6274 |